Cargando…
Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review
Urothelial carcinoma therapy is a rapidly evolving and expanding field. Traditional cytotoxic chemotherapy regimens have not produced optimal long-term outcomes, and many urothelial cancer patients have comorbidities that disqualify them as chemotherapy candidates. In recent years, a plethora of nov...
Autores principales: | Nelson, Blessie Elizabeth, Hong, Angelina, Jana, Bagi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374860/ https://www.ncbi.nlm.nih.gov/pubmed/34422659 http://dx.doi.org/10.3389/fonc.2021.705294 |
Ejemplares similares
-
A unique case of hemolytic‐uremic syndrome secondary to enteropathogenic E Coli
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2020) -
Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021) -
Case of HER2neu+ Invasive Pleomorphic Lobular Carcinoma With Response to Conventional Neoadjuvant Chemotherapy: A Viable Option for an Exceedingly Rare Breast Cancer Type
por: Nelson, Blessie, et al.
Publicado: (2020) -
Papillary urothelial carcinoma of the vagina: A case presentation and review of the literature
por: Razdan, Shirin, et al.
Publicado: (2019) -
HER2 expression in urothelial carcinoma, a systematic literature review
por: Scherrer, Emilie, et al.
Publicado: (2022)